These 9 biotech stocks have doubled this year and are set to double again, analysts say

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 72%

Jasper Therapeutics Inc News

Praxis Precision Medicines Inc,Corbus Pharmaceuticals Holdings Inc,Rezolute Inc

The bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.

Nine health-care stocks have more than doubled in price this year, but still have more than 100% upside potential, according to analysts.

Pro screened more than 85,000 firms worldwide for stocks that have risen by 100% so far in 2024. They are all covered by at least five or more analysts, and a have a median price target pointing to more than 100% upside potential over the next 12 months. The Nasdaq-listed stocks are Jasper Therapeutics , Corbus Pharmaceuticals , Rezolute , Trevi Therapeutics , Delcath Systems , Benitec Biopharma , Arcutis Biotherapeutics , Praxis Precision Medicines and Humacyte .

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines